Reversible, orally available ADP receptor (P2Y12) antagonists Part I: Hit to lead process-Reference-Cited by-同舟云学术

Reversible, orally available ADP receptor (P2Y12) antagonists Part I: Hit to lead process

Published:2018-05 Issue:9 Volume:28 Page:1459-1463
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Islam Imadul,Yuan Shendong,Wei Robert G.,Xu Wei,Morrissey Michael,Mohan Raju,Zheng Dewan,DiMella Andrea,Dunning Laura,Snider Michael,Subramanyam Babu,Tseng Jih-Lie,Bryant Judi A.,Buckman Brad O.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference31 articles.

1. Collaborative overview of randomized trials of antiplatelet therapy I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients;BMJ,1994

2. CAPRIE Steering Committee; Lancet 1996;348:1329.

3. Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation

4. Clopidogrel: An Antithrombotic Drug Acting on the ADP-dependent Activation Pathway of Human Platelets

5. Identification and Biological Activity of the Active Metabolite of Clopidogrel

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QSAR, structure-based pharmacophore modelling and biological evaluation of novel platelet ADP receptor (P2Y₁₂) antagonist;RSC Medicinal Chemistry;2023

2. P2Y12 antagonists: Approved drugs, potential naturally isolated and synthesised compounds, and related in-silico studies;European Journal of Medicinal Chemistry;2022-01

3. Improved Practical Synthesis of DY‐038, an Oral Available Antiplatelet Agent;ChemistrySelect;2021-04

4. Synthesis of (R) and (S)-3-Chloro-5-(2,4-dimethylpiperazin-1-yl)-4H-1,2,6-thiadiazin-4-ones;Molbank;2020-06-01

5. Pharmacology of P2Y receptors;Brain Research Bulletin;2019-09